U.N. High-Level Panel To Examine How IP, Trade Rules, Human Rights Law Affect Access To Medicines
Global Health Technologies Coalitions’ “Breakthroughs”: Setting the stage: U.N. High-Level Panel on Access to Medicines to consider IP, trade, human rights, and access to medicine
Courtney Carson, GHTC’s senior policy and advocacy associate, discusses the work surrounding the U.N. High-Level Panel on Access to Medicines, which is “designed to consider ways in which intellectual property (IP) protections, trade rules, and international human rights law might affect global access to medicine and the ability of the international community to achieve [Sustainable Development Goal (SDG)] three by 2030” (1/28).